Software stock Oracle (ORCL) is powering the Nasdaq today amid news of its joint venture with SoftBank and OpenAI
Oracle Corporation (NYSE:ORCL) shares are trading higher premarket on Wednesday. On Tuesday, the company disclosed new AI agents and generative AI features in Oracle Fusion Cloud Sales to enhance sales engagement and streamline processes.
Oracle (ORCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Oracle's stock surges 8.51% after Trump announces $500B AI initiative, solidifying its role as a key AI provider. CEO Ellison's stake also rises.
On his second day in office, President Donald Trump shook up the tech world when he announced Stargate, a $500 billion investment into infrastructure for artificial intelligence (AI). Oracle (ORCL), SoftBank (SFTBY),
Live Updates Make sure to refresh this page periodically for updates. Earnings to Watch Today 9:37 am Here are some earnings to watch this morning. We’ll provide updates on other market movers as the day progresses.
We recently published a list of 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against other buzzing AI stocks on latest news and ratings.
In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Oracle (ORCL – Research Report), with a price
Netflix stock soars on better-than-expected results, U.S. stock futures gain as investors evaluate moves by President Donald Trump, and Oracle shares jump on major AI infrastructure investment with OpenAI,
Software stock Oracle (ORCL) has pulled back to a historically bullish trendline, and it may be time to "buy the dip."
Oracle Corp (ORCL) stock has tumbled since releasing earnings on Dec. 9 for its fiscal year ending Nov. 30. But the company generated strong FCF and ORCL stock looks at least 16% undervalued here. Based on our FCF analysis ORCL could be worth over $190 per share.